vimarsana.com
Home
Live Updates
INHALE-3 Study's Initial Meal Challenge Results Comparing Af
INHALE-3 Study's Initial Meal Challenge Results Comparing Af
INHALE-3 Study's Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps -March 11, 2024 at 06:05 am EDT
Post-meal hyperglycemia was significantly reduced by 20% with inhaled insulin compared with rapid-acting insulin delivered through MDI or insulin pumpsSubjects utilizing inhaled insulin experienced a...
Related Keywords
United States ,
American ,
Kevin Kaiserman ,
Christie Iacangelo ,
Rose Alinaya ,
Mannkind Corporation Nasdaq ,
Mannkind Corporation ,
Clinical Development ,
University Of Washington ,
American Diabetes Association ,
Exchange Commission ,
Corporate Communications ,
Globenewswire Inc ,
Facebook ,
Linkedin ,
International Conference On Advanced Technologies ,
Scientific Sessions ,
Kind Corporation ,
Advanced Technologies ,
Diabetes Treatment ,
Teaching Chair ,
Senior Vice President ,
Medical Affairs ,
Inhalation Powder ,
Important Safety Information ,
Full Prescribing Information ,
Annual Report ,
Investor Relations ,